US Pharma Firm Receives €922 Million Tax Break in Netherlands

A US pharmaceutical company has been granted a €922 million 'innovation' tax break in the Netherlands, accounting for a significant portion of the country's total tax incentives for innovative firms last year.

13 Apr, 07:24 — 13 Apr, 07:24

Post Share

Sources

Showing 1 of 1 sources

dutchnewsMostly Factual2h ago

US pharma firm gets €922 million “innovation” tax break in NL

Some 90% of the €2.9 billion tax break given to innovative companies in the Netherlands last year has gone to...

By Robin Pascoe

Read full article →

PERSPECTA

PERSPECTA

US Pharma Firm Receives €922 Million Tax Break in Netherlands

Sources

US pharma firm gets €922 million “innovation” tax break in NL

Related Stories

Oil Jumps Above $100 After US-Iran Talks Fail

Philippine Lawmaker Urges Executive Secretary to Allow VAT Cuts on Fuel

Major Fuel Price Rollback in the Philippines

Latvians Expect Stagnant or Decreasing Incomes, Living in Austerity

PERSPECTA